pembroliimab rash with edema and desquamation - cancer patient

antineoplastic breakthrough cachexia cancer chemotherapy cutaneous dermatological desquamation discontinuation edema malignancies medication melanoma nsclc patient pdl1 pembrolizumab prednisone revolution revolutionary sideeffect steroids treatment